Unknown

Dataset Information

0

Development and validation of a predictive mortality risk score from a European hemodialysis cohort.


ABSTRACT: Although mortality risk scores for chronic hemodialysis (HD) patients should have an important role in clinical decision-making, those currently available have limited applicability, robustness, and generalizability. Here we applied a modified Framingham Heart Study approach to derive 1- and 2-year all-cause mortality risk scores using a 11,508 European incident HD patient database (AROii) recruited between 2007 and 2009. This scoring model was validated externally using similar-sized Dialysis Outcomes and Practice Patterns Survey (DOPPS) data. For AROii, the observed 1- and 2-year mortality rates were 13.0 (95% confidence interval (CI; 12.3-13.8)) and 11.2 (10.4-12.1)/100 patient years, respectively. Increasing age, low body mass index, history of cardiovascular disease or cancer, and use of a vascular access catheter during baseline were consistent predictors of mortality. Among baseline laboratory markers, hemoglobin, ferritin, C-reactive protein, serum albumin, and creatinine predicted death within 1 and 2 years. When applied to the DOPPS population, the predictive risk score models were highly discriminatory, and generalizability remained high when restricted by incidence/prevalence and geographic location (C-statistics 0.68-0.79). This new model offers improved predictive power over age/comorbidity-based models and also predicted early mortality (C-statistic 0.71). Our new model delivers a robust and reproducible mortality risk score, based on readily available clinical and laboratory data.

SUBMITTER: Floege J 

PROVIDER: S-EPMC4424813 | biostudies-other | 2015 May

REPOSITORIES: biostudies-other

altmetric image

Publications

Development and validation of a predictive mortality risk score from a European hemodialysis cohort.

Floege Jürgen J   Gillespie Iain A IA   Kronenberg Florian F   Anker Stefan D SD   Gioni Ioanna I   Richards Sharon S   Pisoni Ronald L RL   Robinson Bruce M BM   Marcelli Daniele D   Froissart Marc M   Eckardt Kai-Uwe KU  

Kidney international 20150204 5


Although mortality risk scores for chronic hemodialysis (HD) patients should have an important role in clinical decision-making, those currently available have limited applicability, robustness, and generalizability. Here we applied a modified Framingham Heart Study approach to derive 1- and 2-year all-cause mortality risk scores using a 11,508 European incident HD patient database (AROii) recruited between 2007 and 2009. This scoring model was validated externally using similar-sized Dialysis O  ...[more]

Similar Datasets

| S-EPMC4254722 | biostudies-literature
| S-EPMC6419404 | biostudies-literature
| S-EPMC7911244 | biostudies-literature
2020-05-05 | GSE132897 | GEO
| S-EPMC6599280 | biostudies-literature
| S-EPMC8341885 | biostudies-literature
| S-EPMC6202558 | biostudies-literature
| S-EPMC7343477 | biostudies-literature
| S-EPMC8687635 | biostudies-literature
| S-EPMC5207446 | biostudies-literature